W Endoluminal Robotics
Formerly AMT
Early Diagnosis and Treatment of Lung Cancer
Startup Seed Health Tech & Life Sciences Est. 2020
Total Raised
$260K
Seed
Last Round
$260K
2 rounds
Investors
1
1 public
Team
2
1-10 employees
Confidence
85/100
Patents
1
About
W Endoluminal Robotics is developing a solution for the early diagnosis and treatment of lung cancer. Its novel mechanical solution and advanced control algorithms enable limitless accessibility to every location within the lungs, with true live confirmation. The company’s technology is revolutionizing diagnostics by increasing certainty in lung biopsies and enabling advanced lung treatment solutions, offering an innovative approach designed to surpass other advanced technologies while reducing the burden on hospitals.
Classification
Sector
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Core Technology
Machinery & Robotics
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
diagnosticsminimally-invasivebiopsymedical-devicesroboticssurgerymedical-technologiescancer
Funding & Events
May 2023
Undisclosed Round $260K
Peregrine Ventures
Jan 2021
Undisclosed Round Undisclosed
Peregrine Ventures (Lead)
Details
Product Stage
R&D
Employees
1-10
Exact Count
2
Founded
2020
Registrar
516261310
Locations
Israel
Links
LinkedIn
Admin
Last Update
Mar 21, 2024
Verified by
Yotam Maman
Missing
homepage, news, markets, not claimed
Team (2)
Eli Shapiro
Co-founder & CEO
Prof. Nir Shvalb
Founder
Founder
Internal
Created by
Yanina Wainscheinker (yanina.wain@gmail.com)
Created
2021-03-29T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)